Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 12:23.
doi: 10.18332/tid/204744. eCollection 2025.

Smoking-related bladder cancer burden from 1990 to 2021: An age-period-cohort analysis of the global burden of disease study

Affiliations

Smoking-related bladder cancer burden from 1990 to 2021: An age-period-cohort analysis of the global burden of disease study

Qingqing Yu et al. Tob Induc Dis. .

Abstract

Introduction: Bladder cancer is common in the elderly, with smoking as a major risk factor. This study assesses the global burden of bladder cancer attributable to smoking, using data from 204 countries and regions (1990-2021).

Methods: Mortality, age-standardized mortality rates (ASMR), disability-adjusted life years (DALYs), and age-standardized DALY rates (ASDR) were extracted from the Global Burden of Disease (GBD) 2021 study. The burden of smoking-related bladder cancer was analyzed by age, gender, and sociodemographic index (SDI).

Results: Between 1990 and 2021, global deaths due to smoking-related bladder cancer increased by 42.9%, while disability rose by 31.0%. In 2021, the global number of bladder cancer deaths due to smoking reached 58766 (95% UI: 49381-70891). Despite these increases, both ASMR and ASDR declined globally. Males experienced a higher increase in mortality and disability, with rates approximately 10 times higher than females. Middle SDI countries saw the largest rise in burden. The annual decline in mortality was 2.06%, greater in males than females.

Conclusions: The burden of smoking-related bladder cancer is higher in males, middle-aged and elderly individuals, and medium to high SDI countries. Targeted prevention and health policies are crucial to reducing the disease's impact on populations and healthcare systems.

Keywords: ageperiod-cohort analysis; bladder cancer; global burden of disease; smoking.

PubMed Disclaimer

Conflict of interest statement

The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none was reported.

Figures

Figure 1
Figure 1
The temporal change of the mortality rate and DALYs in bladder cancer attributable to smoking across age groups: A, C) The relative proportion of bladder cancer mortality and DALYs; B, D) The temporal changes in the mortality rate and DALYs of bladder cancer
Figure 2
Figure 2
The local drifts, age effects, period effects, and cohort effects of bladder cancer mortality attributable to smoking from 1990 to 2021: A–D) mortality data; E–H) DALYs

Similar articles

Cited by

References

    1. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17-48. doi: 10.3322/caac.21763 - DOI - PubMed
    1. van Hoogstraten LMC, Vrieling A, van der Heijden AG, Kogevinas M, Richters A, Kiemeney LA. Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat Rev Clin Oncol. 2023;20(5):287-304. doi: 10.1038/s41571-023-00744-3 - DOI - PubMed
    1. Zi H, He SH, Leng XY, et al. Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990-2019. Mil Med Res. 2021;8(1):60. doi: 10.1186/s40779-021-00354-z - DOI - PMC - PubMed
    1. Jubber I, Ong S, Bukavina L, et al. Epidemiology of bladder cancer in 2023: a systematic review of risk factors. Eur Urol. 2023;84(2):176-190. doi: 10.1016/j.eururo.2023.03.029 - DOI - PubMed
    1. Lammers RJ, Witjes WP, Hendricksen K, Caris CT, JanzingPastors MH, Witjes JA. Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer. Eur Urol. 2011;60(4):713-720. doi: 10.1016/j.eururo.2011.07.010 - DOI - PubMed

LinkOut - more resources